.avif)
Orchid Health offers advanced whole-genome screening for embryos during IVF, detecting over 1,100 genes for monogenic disorders, chromosomal abnormalities, and genetic risk scores for 25+ complex diseases. Their technology sequences 99% of an embryo's DNA and integrates multiple preimplantation genetic testing modalities (PGT-A, PGT-M, PGT-SR, PGT-P). The company is CAP and CLIA certified and has published peer-reviewed validation studies on high-fidelity embryo sequencing.
.svg)
